Large vaccine trials that are extensive both in size and scope tax the resources of sponsors and contract research organizations (CROs), particularly when the trials seek to compress a process that ordinarily takes years. Rapid but safe implementation of these vaccine studies’ new protocols is pushing trial design to the limit.
A federal judge tossed out whistleblower lawsuits alleging that pharmaceutical giants Eli Lilly and Bayer used nurses to illegally boost sales of various prescription drugs in a kickback scheme.
Even experienced pharma marketers who may have years of developing marketing and communication strategies for hospitals and/or vertically integrated systems might not fully understand and appreciate the critical needs and differentiators of inpatient physicians. With the way this increasingly important channel has quickly evolved, driven by healthcare reform and the value-based reimbursement environment, how can they not only keep up but get out ahead of the needs and solutions this market requires? How will they learn what they need to know to position their products for success? The answer is by listening and partnering.
Nurse practitioners are seeing annual net incomes surpass $100,000 as their roles expand amid a doctor shortage, changing state regulations and the push toward team-based approaches to keeping patients healthy and costs in check. A new report by the American Association of Nurse Practitioners shows total annual income increasing this year to $108,643 from $98,760 […]